Health Care & Life Sciences » Pharmaceuticals | Northeast Pharmaceutical Group Co. Ltd.

Northeast Pharmaceutical Group Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,840
4,301
3,816
4,752
5,602
7,372
Cost of Goods Sold (COGS) incl. D&A
2,724
3,016
2,869
3,348
3,513
4,478
Gross Income
1,117
1,285
947
1,403
2,089
2,894
SG&A Expense
1,130
1,070
1,139
1,197
1,775
2,709
EBIT
44
161
263
162
263
175
Unusual Expense
-
1
3
16
35
9
Non Operating Income/Expense
15
70
5
11
24
189
Interest Expense
163
172
157
167
164
173
Pretax Income
159
106
407
37
102
214
Income Tax
6
22
15
11
10
12
Consolidated Net Income
165
84
392
26
92
201
Net Income
167
87
384
24
119
195
Net Income After Extraordinaries
167
87
384
24
119
195
Net Income Available to Common
167
87
384
24
119
195
EPS (Basic)
0.50
0.22
0.81
0.05
0.25
0.36
Basic Shares Outstanding
334
396
475
475
475
542
EPS (Diluted)
0.50
0.22
0.81
0.05
0.25
0.36
Diluted Shares Outstanding
334
396
475
475
475
542
EBITDA
105
333
49
451
591
499
Other Operating Expense
30
54
71
44
50
9
Non-Operating Interest Income
14
28
24
31
31
31
Minority Interest Expense
2
3
8
3
27
6

About Northeast Pharmaceutical Group Co.

View Profile
Address
Shenyang Economics & Tech Dev Zone
Shenyang Liaoning 110027
China
Employees -
Website http://www.nepharm.com.cn
Updated 07/08/2019
Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sales of pharmaceutical products. It is doing business through three major segments-chemical synthetic API & bio-fermentation API, western medicinal preparation & micro-ecological preparation and medical business distribution. Its products include antibiotics, antiviral, anti-infective, antipyretic analgesic, vitamin & obstetrics series, nervous system, cardiovascular system, digestive system, biological diagnosis, respiratory drugs, food & feed additives and nutraceuticals, nutrition and decontamination products.